Search results
Author(s):
Samineh Sehatbakhsh
Added:
3 months ago
Explore comprehensive lifetime management strategies for aortic stenosis with Dr Samineh Sehatbakhsh, addressing the evolving landscape of treatment options for patients across all risk categories.This detailed presentation, part of the Complex Cases track, examines the critical decision-making process between TAVR and surgical aortic valve replacement in the modern era. Dr Sehatbakhsh addresses…
View more
Author(s):
Jack Tan Wei Chieh
,
Huay Cheem Tan
,
Michael Kang-Yin Lee
,
et al
Added:
1 year ago
Author(s):
Jonathan Yap
,
Kentaro Hayashida
,
Michael Kang-Yin Lee
,
et al
Added:
1 year ago
Author(s):
Ivan Wong
,
Michael Chiang
,
Angus Shing Fung Chui
,
et al
Added:
1 year ago
Author(s):
Tiana Chen
,
Yu Ren
,
Wei Liu
,
et al
Added:
4 months ago
Author(s):
Patrick W Serruys
Added:
6 months ago
EuroPCR 25 - Novel Myval THV shows non-inferiority at one year compared to established valves in severe aortic stenosis.We are joined by Dr Patrick Serruys (Erasmus University Medical Center, Rotterdam, NL) to discuss key findings from the LANDMARK trial.This multinational, multicentric, randomized controlled trial compared the safety and effectiveness of the Myval THV Series against contemporary…
View more
Author(s):
Arvinjay A Bautista
,
Danilo S Kuizon
Added:
1 year ago
Author(s):
Reynald Evan R Tugade
,
Monica D Reyes-Sindiong
,
Fatima R Collado
Added:
1 year ago
Author(s):
Nicolas M Van Mieghem
Added:
1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)…
View more
Author(s):
Moritz Seiffert
Added:
1 year ago
ACC.24 — Investigator Dr Moritz Seiffert (University Heart and Vascular Center Hamburg, DE) joins us onsite at ACC to discuss the findings of the DEDICATE-DZHK6 Trial (NCT03112980).This randomized controlled, multi-center trial aimed to investigate whether transcatheter aortic valve implantation (TAVI) is non-inferior to surgical aortic valve replacement (SAVR) in patients with symptomatic severe…
View more